Literature DB >> 23420457

Effect of statin treatments on highly pathogenic avian influenza H5N1, seasonal and H1N1pdm09 virus infections in BALB/c mice.

Yohichi Kumaki1, John D Morrey, Dale L Barnard.   

Abstract

Statins are used to control elevated cholesterol or hypercholesterolemia, but have previously been reported to have antiviral properties. AIMS: To show efficacy of statins in various influenza virus mouse models. MATERIALS &
METHODS: BALB/c mice were treated intraperitoneally or orally with several types of statins (simvastatin, lovastatin, mevastatin, pitavastatin, atorvastatin or rosuvastatin) at various concentrations before or after infection with either influenza A/Duck/ MN/1525/81 H5N1 virus, influenza A/Vietnam/1203/2004 H5N1 virus, influenza A/ Victoria/3/75 H3N2 virus, influenza A/NWS/33 H1N1 virus or influenza A/CA/04/09 H1N1pdm09 virus.
RESULTS: The statins administered intraperitoneally or orally at any dose did not significantly enhance the total survivors relative to untreated controls. In addition, infected mice receiving any concentration of statin were not protected against weight loss due to the infection. None of the statins significantly increased the mean day of death relative to mice in the placebo treatment group. Furthermore, the statins had relatively few ameliorative effects on lung pathology or lung weights at day 3 and 6 after virus exposure, although mice treated with simvastatin did have improved lung function as measured by arterial saturated oxygen levels in one experiment.
CONCLUSION: Statins showed relatively little efficacy in any mouse model used by any parameter tested.

Entities:  

Keywords:  BALB/c mouse; anti-inflammatory; atorvastatin; influenza virus; lovastatin; mevastatin; pitavastatin; rosuvastatin; simvastatin; statin

Year:  2012        PMID: 23420457      PMCID: PMC3571729          DOI: 10.2217/fvl.12.71

Source DB:  PubMed          Journal:  Future Virol        ISSN: 1746-0794            Impact factor:   1.831


  71 in total

1.  Effects of simvastatin in patients with viral chronic hepatitis C.

Authors:  Romeo-Gabriel Mihaila; Laurentiu Nedelcu; Ovidiu Fratila; Laura Retzler; Carmen Domnariu; Remus-Calin Cipaian; Elena-Cristina Rezi; Corina Beca; Mircea Deac
Journal:  Hepatogastroenterology       Date:  2011 Jul-Aug

2.  The hemagglutinin protein of influenza A/Vietnam/1203/2004 (H5N1) contributes to hyperinduction of proinflammatory cytokines in human epithelial cells.

Authors:  Xing Cheng; Qi Xu; Eyun Song; Chin-Fen Yang; George Kemble; Hong Jin
Journal:  Virology       Date:  2010-07-27       Impact factor: 3.616

Review 3.  Avian influenza A (H5N1) infection in humans.

Authors:  John H Beigel; Jeremy Farrar; Aye Maung Han; Frederick G Hayden; Randy Hyer; Menno D de Jong; Sorasak Lochindarat; Thi Kim Tien Nguyen; Tran Hien Nguyen; Tinh Hien Tran; Angus Nicoll; Sok Touch; Kwok-Yung Yuen
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

Review 4.  The inflammation hypothesis and its potential relevance to statin therapy.

Authors:  James S Forrester; Peter Libby
Journal:  Am J Cardiol       Date:  2007-01-10       Impact factor: 2.778

5.  Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study.

Authors:  Meredith L Vandermeer; Ann R Thomas; Laurie Kamimoto; Arthur Reingold; Ken Gershman; James Meek; Monica M Farley; Patricia Ryan; Ruth Lynfield; Joan Baumbach; William Schaffner; Nancy Bennett; Shelley Zansky
Journal:  J Infect Dis       Date:  2011-12-13       Impact factor: 5.226

6.  Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice.

Authors:  Donald F Smee; Brett L Hurst; Min-Hui Wong; Kevin W Bailey; E Bart Tarbet; John D Morrey; Yousuke Furuta
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

Review 7.  The pathology of influenza virus infections.

Authors:  Jeffery K Taubenberger; David M Morens
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

8.  Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins.

Authors:  Floyd J Frost; Hans Petersen; Kristine Tollestrup; Betty Skipper
Journal:  Chest       Date:  2007-04       Impact factor: 9.410

9.  In vitro and in vivo activities of T-705 and oseltamivir against influenza virus.

Authors:  Kazumi Takahashi; Yousuke Furuta; Yoshiko Fukuda; Masako Kuno; Tomoko Kamiyama; Kyo Kozaki; Nobuhiko Nomura; Hiroyuki Egawa; Shinzaburo Minami; Kimiyasu Shiraki
Journal:  Antivir Chem Chemother       Date:  2003-09

10.  A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection.

Authors:  David Marsolais; Bumsuk Hahm; Kevin B Walsh; Kurt H Edelmann; Dorian McGavern; Yasuko Hatta; Yoshihiro Kawaoka; Hugh Rosen; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

View more
  17 in total

1.  Type I Interferon Counteracts Antiviral Effects of Statins in the Context of Gammaherpesvirus Infection.

Authors:  Philip T Lange; Eric J Darrah; Emily P Vonderhaar; Wadzanai P Mboko; Michaela M Rekow; Shailendra B Patel; Duska J Sidjanin; Vera L Tarakanova
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

2.  Roles of the Mevalonate Pathway and Cholesterol Trafficking in Pulmonary Host Defense.

Authors:  Kristin A Gabor; Michael B Fessler
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

Review 3.  The inflammatory response triggered by Influenza virus: a two edged sword.

Authors:  Luciana P Tavares; Mauro M Teixeira; Cristiana C Garcia
Journal:  Inflamm Res       Date:  2016-10-15       Impact factor: 4.575

Review 4.  The controversy over H5N1 transmissibility research: an opportunity to define a practical response to a global threat.

Authors:  David S Fedson; Steven M Opal
Journal:  Hum Vaccin Immunother       Date:  2013-02-07       Impact factor: 3.452

5.  Anti-Influenza Drug Discovery and Development: Targeting the Virus and Its Host by All Possible Means.

Authors:  Olivier Terrier; Anny Slama-Schwok
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Simvastatin attenuates rhinovirus-induced interferon and CXCL10 secretion from monocytic cells in vitro.

Authors:  Lisa E Wickert; Maya R Karta; Anjon Audhya; James E Gern; Paul J Bertics
Journal:  J Leukoc Biol       Date:  2014-02-14       Impact factor: 4.962

Review 7.  Mechanisms of action and efficacy of statins against influenza.

Authors:  Parvaneh Mehrbod; Abdul Rahman Omar; Mohd Hair-Bejo; Amin Haghani; Aini Ideris
Journal:  Biomed Res Int       Date:  2014-11-11       Impact factor: 3.411

8.  Influenza virus A/Anhui/1/2013 (H7N9) replicates efficiently in the upper and lower respiratory tracts of cynomolgus macaques.

Authors:  Emmie de Wit; Angela L Rasmussen; Friederike Feldmann; Trenton Bushmaker; Cynthia Martellaro; Elaine Haddock; Atsushi Okumura; Sean C Proll; Jean Chang; Don Gardner; Michael G Katze; Vincent J Munster; Heinz Feldmann
Journal:  mBio       Date:  2014-08-12       Impact factor: 7.867

Review 9.  How to approach and treat viral infections in ICU patients.

Authors:  Theodoros Kelesidis; Ioannis Mastoris; Aliki Metsini; Sotirios Tsiodras
Journal:  BMC Infect Dis       Date:  2014-11-28       Impact factor: 3.667

Review 10.  Multi-Omics Studies towards Novel Modulators of Influenza A Virus-Host Interaction.

Authors:  Sandra Söderholm; Yu Fu; Lana Gaelings; Sergey Belanov; Laxman Yetukuri; Mikhail Berlinkov; Anton V Cheltsov; Simon Anders; Tero Aittokallio; Tuula A Nyman; Sampsa Matikainen; Denis E Kainov
Journal:  Viruses       Date:  2016-09-29       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.